Example: Heart Attack

Clinical Trials Sponsored by AstraZeneca

Total 4044 results

NCT05891847

Recruiting

Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia

Neurofibroma
NCT05892926

Not yet recruiting

HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia

Adenocarcinoma
NCT05888857

Not yet recruiting

A Multicentric Phase II Trial Evaluating MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. (TAYLOR)

Advanced Solid Tumor
NCT05888207

Not yet recruiting

A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Healthy Male Subjects
NCT05887011

Recruiting

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC in Routine Practices in Russia (PASSAT)

Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
NCT05886244

Not yet recruiting

Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China (Soliris)

Paroxysmal Nocturnal Hemoglobinuria
NCT05883644

Not yet recruiting

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) (SIERRA)

Advanced Hepatocellular Carcinoma
NCT05885009

Recruiting

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) (HOPE-PROSTATE)

Metastatic Prostate Cancer
NCT05876351

Not yet recruiting

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China (Soliris)

Atypical Hemolytic Uremic
NCT05872958

Recruiting

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

COVID-19
NCT05866276

Not yet recruiting

A Study To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patient

Normal Adult Population in Asia
NCT05864391

Recruiting

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Steatohepatitis
NCT05862545

Not yet recruiting

Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol) (CHOROS ORION)

Chronic Obstructive Pulmonary Disease
NCT05859048

Not yet recruiting

Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure (MAPLE-CHF)

Heart Failure
NCT05850494

Recruiting

Study to Assess Bronchospasm Potentially Induced by HFO vs HFA MDI in Participants With Well/Partially Controlled Asthma

Asthma
NCT05848440

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants

Non-alcoholic Steatohepatitis
NCT05848843

Not yet recruiting

A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations

Lung Cancer | Gastro-intestinal Cancer
NCT05847140

Not yet recruiting

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy (O-STEREO)

Pregnancy | Pregnant Women | Pregnancy Outcome
NCT05835778

Not yet recruiting

Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Biliary Tract Cancer
NCT05835310

Not yet recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants (SLE)

Systemic Lupus Erythematosus
NCT05832008

Not yet recruiting

Increasing Adherence to Lung Cancer Screening

Lung Cancer | Adherence, Patient
NCT05826366

Not yet recruiting

Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Carcinoma, Non-Small-Cell Lung
NCT05825365

Not yet recruiting

Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study (PROTECT)

Neurofibromatosis Type 1 | Plexiform Neurofibromas | Post-operative
NCT05826756

Recruiting

Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting (PEER)

Caregivers | Lung Cancer Patients
NCT05820841

Recruiting

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma (ARCHED)

Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma
NCT05821231

Not yet recruiting

Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma (MEDISARC-SBRT)

Soft Tissue Sarcoma
NCT05818514

Recruiting

A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants

Healthy Volunteers
NCT05817461

Recruiting

An ADME Study of [14C]AZD0780 in Healthy Male Subjects

Cardiovascular Diseases
NCT05817110

Recruiting

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule. (CREATE)

Lung Malignancy
NCT05809934

Recruiting

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis (FORTUNA)

Nonalcoholic Steatohepatitis
NCT05801029

Not yet recruiting

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations (OSTARA)

Non-Small Cell Lung Cancer (NSCLC)
NCT05797168

Not yet recruiting

Phase I/IIa Study for AZD5335 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors (FONTANA)

Ovarian Cancer | Lung Adenocarcinoma
NCT05795101

Recruiting

TRUDI: TDXD+Durva in HER2+/Low IBC (TRUDI)

Breast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast Adenocarcinoma
NCT05794672

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects

Healthy Subjects (Indication: Asthma)
NCT05796089

Recruiting

TROG 20.01 CHEST RT: Chemotherapy and Immunotherapy in Extensive Stage Small Cell Lung Cancer With Thoracic Radiotherapy

Extensive-stage Small-cell Lung Cancer

Clinical Trials Sponsored by AstraZeneca

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations